1,3-cyclopentadiene has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, M; Bland, JS; Carroll, BJ; Darland, G; Desai, A; Konda, VR; Prabhu, KS; Tripp, ML | 1 |
| Bland, JS; Darland, G; Desai, A; Konda, VR; Tripp, ML | 1 |
2 other study(ies) available for 1,3-cyclopentadiene and Innate Inflammatory Response
| Article | Year |
|---|---|
META060 inhibits multiple kinases in the NF-kappaB pathway and suppresses LPS--mediated inflammation in vitro and ex vivo.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cyclooxygenase 2; Cyclopentanes; Dinoprostone; Humans; Inflammation; Interleukin-6; Lipopolysaccharides; Macrophages; Mice; Molecular Structure; NF-kappa B; Nitric Oxide; Protein Kinase Inhibitors; Signal Transduction; Tumor Necrosis Factor-alpha | 2009 |
META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Blotting, Western; Bone and Bones; Cartilage; Cell Differentiation; Cyclopentanes; Disease Models, Animal; Inflammation; Interleukin-6; Matrix Metalloproteinases; Mice; NF-kappa B; Osteoclasts; RANK Ligand | 2010 |